As of December 2025 Blueprint Medicines has a market cap of A$12.62 Billion. This makes Blueprint Medicines the world's 2200th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.